nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—HTR1B—cranial nerve—salivary gland cancer	0.0364	0.145	CbGeAlD
Haloperidol—HTR1D—cranial nerve—salivary gland cancer	0.0352	0.141	CbGeAlD
Haloperidol—HTR2A—cranial nerve—salivary gland cancer	0.0175	0.0698	CbGeAlD
Haloperidol—H1F0—neck—salivary gland cancer	0.0131	0.0523	CbGeAlD
Haloperidol—CBR1—parotid gland—salivary gland cancer	0.013	0.0519	CbGeAlD
Haloperidol—CBR1—saliva-secreting gland—salivary gland cancer	0.0125	0.0497	CbGeAlD
Haloperidol—H1F0—parotid gland—salivary gland cancer	0.0107	0.0426	CbGeAlD
Haloperidol—H1F0—saliva-secreting gland—salivary gland cancer	0.0102	0.0408	CbGeAlD
Haloperidol—H1F0—connective tissue—salivary gland cancer	0.00938	0.0375	CbGeAlD
Haloperidol—CBR1—lymphoid tissue—salivary gland cancer	0.00837	0.0334	CbGeAlD
Haloperidol—SIGMAR1—parotid gland—salivary gland cancer	0.0077	0.0307	CbGeAlD
Haloperidol—SIGMAR1—saliva-secreting gland—salivary gland cancer	0.00737	0.0294	CbGeAlD
Haloperidol—HTR1D—connective tissue—salivary gland cancer	0.00727	0.029	CbGeAlD
Haloperidol—H1F0—lymphoid tissue—salivary gland cancer	0.00686	0.0274	CbGeAlD
Haloperidol—CYP1A1—parotid gland—salivary gland cancer	0.00517	0.0207	CbGeAlD
Haloperidol—HTR2A—neck—salivary gland cancer	0.00504	0.0201	CbGeAlD
Haloperidol—CBR1—lymph node—salivary gland cancer	0.00472	0.0189	CbGeAlD
Haloperidol—CYP1A1—epithelium—salivary gland cancer	0.00432	0.0173	CbGeAlD
Haloperidol—HRH1—connective tissue—salivary gland cancer	0.00432	0.0173	CbGeAlD
Haloperidol—HRH1—epithelium—salivary gland cancer	0.0041	0.0164	CbGeAlD
Haloperidol—H1F0—lymph node—salivary gland cancer	0.00387	0.0155	CbGeAlD
Haloperidol—HTR2A—connective tissue—salivary gland cancer	0.00361	0.0144	CbGeAlD
Haloperidol—HTR2A—epithelium—salivary gland cancer	0.00343	0.0137	CbGeAlD
Haloperidol—SIGMAR1—lymph node—salivary gland cancer	0.0028	0.0112	CbGeAlD
Haloperidol—HTR2B—lymph node—salivary gland cancer	0.00279	0.0111	CbGeAlD
Haloperidol—ABCB1—epithelium—salivary gland cancer	0.00225	0.00897	CbGeAlD
Haloperidol—KCNH2—lymph node—salivary gland cancer	0.00222	0.00888	CbGeAlD
Haloperidol—CYP1A1—lymph node—salivary gland cancer	0.00188	0.0075	CbGeAlD
Haloperidol—HRH1—lymph node—salivary gland cancer	0.00178	0.00712	CbGeAlD
Haloperidol—ABCB1—lymphoid tissue—salivary gland cancer	0.00173	0.00691	CbGeAlD
Haloperidol—ABCB1—lymph node—salivary gland cancer	0.000976	0.0039	CbGeAlD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000241	0.000321	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PHGDH—salivary gland cancer	0.000239	0.000319	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—JAG1—salivary gland cancer	0.000237	0.000317	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—FGFR4—salivary gland cancer	0.000236	0.000315	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PHGDH—salivary gland cancer	0.000233	0.000311	CbGpPWpGaD
Haloperidol—EBP—Metabolism—PIK3CA—salivary gland cancer	0.000233	0.000311	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	0.000233	0.000311	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—FBXW7—salivary gland cancer	0.000233	0.00031	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ST3GAL4—salivary gland cancer	0.00023	0.000307	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.00023	0.000307	CbGpPWpGaD
Haloperidol—CBR1—Metabolism—PIK3CA—salivary gland cancer	0.000229	0.000306	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PYGB—salivary gland cancer	0.000229	0.000305	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—FGF16—salivary gland cancer	0.000228	0.000304	CbGpPWpGaD
Haloperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—salivary gland cancer	0.000227	0.000303	CbGpPWpGaD
Haloperidol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—salivary gland cancer	0.000227	0.000303	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	0.000225	0.0003	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—FGF16—salivary gland cancer	0.000224	0.000299	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—JAG1—salivary gland cancer	0.000224	0.000299	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—FGF16—salivary gland cancer	0.000224	0.000299	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—FGFR4—salivary gland cancer	0.000223	0.000298	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—JAG1—salivary gland cancer	0.000221	0.000295	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—FGFR4—salivary gland cancer	0.00022	0.000294	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PHGDH—salivary gland cancer	0.00022	0.000293	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—FBXW7—salivary gland cancer	0.000219	0.000293	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000219	0.000293	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PHGDH—salivary gland cancer	0.000218	0.000291	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—FBXW7—salivary gland cancer	0.000216	0.000289	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—NUP62—salivary gland cancer	0.000214	0.000286	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—FOXO3—salivary gland cancer	0.000213	0.000285	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—VCAN—salivary gland cancer	0.000213	0.000284	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ST3GAL4—salivary gland cancer	0.000212	0.000282	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ST3GAL4—salivary gland cancer	0.00021	0.00028	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000209	0.000279	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—AQP1—salivary gland cancer	0.000209	0.000279	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—FOXO3—salivary gland cancer	0.000209	0.000279	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—FOXO3—salivary gland cancer	0.000206	0.000274	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—AQP1—salivary gland cancer	0.000204	0.000272	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—NUP62—salivary gland cancer	0.000203	0.00027	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—VCAN—salivary gland cancer	0.000201	0.000268	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MAML2—salivary gland cancer	0.000198	0.000264	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—FOXO3—salivary gland cancer	0.000196	0.000262	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MAML2—salivary gland cancer	0.000195	0.00026	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MAML2—salivary gland cancer	0.000194	0.000259	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000193	0.000258	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—AQP1—salivary gland cancer	0.000192	0.000257	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—AQP1—salivary gland cancer	0.000191	0.000254	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00019	0.000254	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—MARCKS—salivary gland cancer	0.00019	0.000253	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00019	0.000253	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PHGDH—salivary gland cancer	0.000186	0.000249	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—FOXO3—salivary gland cancer	0.000185	0.000247	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—FOXO3—salivary gland cancer	0.000183	0.000244	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ST3GAL4—salivary gland cancer	0.000179	0.000239	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PYGB—salivary gland cancer	0.000176	0.000235	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000176	0.000235	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—MAP2K2—salivary gland cancer	0.000174	0.000232	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—MAP2K2—salivary gland cancer	0.000171	0.000228	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.00017	0.000227	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—JAG1—salivary gland cancer	0.000169	0.000226	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—FGFR4—salivary gland cancer	0.000168	0.000225	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—MAP2K2—salivary gland cancer	0.000168	0.000224	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—JAG1—salivary gland cancer	0.000166	0.000222	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—JAG1—salivary gland cancer	0.000166	0.000221	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—NUP62—salivary gland cancer	0.000166	0.000221	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—FGFR4—salivary gland cancer	0.000166	0.000221	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—FBXW7—salivary gland cancer	0.000166	0.000221	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—FGFR4—salivary gland cancer	0.000165	0.000221	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—VCAN—salivary gland cancer	0.000164	0.000219	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000164	0.000219	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—FBXW7—salivary gland cancer	0.000163	0.000217	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—AQP1—salivary gland cancer	0.000163	0.000217	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—FBXW7—salivary gland cancer	0.000163	0.000217	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—NUP62—salivary gland cancer	0.000162	0.000216	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—VCAN—salivary gland cancer	0.000161	0.000214	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MAP2K2—salivary gland cancer	0.00016	0.000214	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000155	0.000206	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—NUP62—salivary gland cancer	0.000152	0.000203	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—VCAN—salivary gland cancer	0.000151	0.000202	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—NUP62—salivary gland cancer	0.000151	0.000202	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000151	0.000202	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—VCAN—salivary gland cancer	0.00015	0.0002	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MAP2K2—salivary gland cancer	0.000149	0.000199	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000144	0.000193	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PHGDH—salivary gland cancer	0.000144	0.000192	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—NOTCH1—salivary gland cancer	0.000143	0.00019	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—NOTCH1—salivary gland cancer	0.00014	0.000186	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—FOXO3—salivary gland cancer	0.00014	0.000186	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	0.000138	0.000185	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—NOTCH1—salivary gland cancer	0.000138	0.000183	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—FOXO3—salivary gland cancer	0.000137	0.000183	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—FOXO3—salivary gland cancer	0.000137	0.000183	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—CREBBP—salivary gland cancer	0.000137	0.000182	CbGpPWpGaD
Haloperidol—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000134	0.000179	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000132	0.000176	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—NOTCH1—salivary gland cancer	0.000131	0.000175	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CREBBP—salivary gland cancer	0.000129	0.000173	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—NUP62—salivary gland cancer	0.000129	0.000172	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—VCAN—salivary gland cancer	0.000128	0.000171	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CREBBP—salivary gland cancer	0.000127	0.000169	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000126	0.000168	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—AQP1—salivary gland cancer	0.000126	0.000168	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CREBBP—salivary gland cancer	0.000125	0.000166	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NOTCH1—salivary gland cancer	0.000124	0.000165	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NOTCH1—salivary gland cancer	0.000122	0.000163	CbGpPWpGaD
Haloperidol—HTR1D—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000122	0.000162	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.00012	0.00016	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CREBBP—salivary gland cancer	0.000119	0.000159	CbGpPWpGaD
Haloperidol—HTR1B—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000119	0.000159	CbGpPWpGaD
Haloperidol—DRD4—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000117	0.000156	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—CREBBP—salivary gland cancer	0.000115	0.000153	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MAP2K2—salivary gland cancer	0.000114	0.000152	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000112	0.00015	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000112	0.00015	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CREBBP—salivary gland cancer	0.000112	0.00015	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000112	0.000149	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000112	0.000149	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CREBBP—salivary gland cancer	0.000111	0.000148	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—PIK3CA—salivary gland cancer	0.00011	0.000147	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000108	0.000144	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000106	0.000142	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000105	0.000141	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000104	0.000139	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000103	0.000138	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—HRAS—salivary gland cancer	0.000102	0.000136	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000102	0.000135	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—HRAS—salivary gland cancer	0.0001	0.000133	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—NUP62—salivary gland cancer	9.97e-05	0.000133	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—VCAN—salivary gland cancer	9.89e-05	0.000132	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—HRAS—salivary gland cancer	9.84e-05	0.000131	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	9.83e-05	0.000131	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PTEN—salivary gland cancer	9.77e-05	0.00013	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CCND1—salivary gland cancer	9.58e-05	0.000128	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—PIK3CA—salivary gland cancer	9.57e-05	0.000128	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—PIK3CA—salivary gland cancer	9.45e-05	0.000126	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	9.4e-05	0.000125	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—HRAS—salivary gland cancer	9.39e-05	0.000125	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CCND1—salivary gland cancer	9.38e-05	0.000125	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NOTCH1—salivary gland cancer	9.35e-05	0.000125	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—EP300—salivary gland cancer	9.31e-05	0.000124	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—PTEN—salivary gland cancer	9.24e-05	0.000123	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CCND1—salivary gland cancer	9.23e-05	0.000123	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NOTCH1—salivary gland cancer	9.2e-05	0.000123	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NOTCH1—salivary gland cancer	9.18e-05	0.000122	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—PTEN—salivary gland cancer	9.05e-05	0.000121	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	8.96e-05	0.00012	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—PTEN—salivary gland cancer	8.9e-05	0.000119	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	8.89e-05	0.000119	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—HRAS—salivary gland cancer	8.86e-05	0.000118	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—EP300—salivary gland cancer	8.81e-05	0.000118	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CCND1—salivary gland cancer	8.81e-05	0.000118	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—HRAS—salivary gland cancer	8.74e-05	0.000117	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—EP300—salivary gland cancer	8.63e-05	0.000115	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—PTEN—salivary gland cancer	8.5e-05	0.000113	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—EP300—salivary gland cancer	8.49e-05	0.000113	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CREBBP—salivary gland cancer	8.48e-05	0.000113	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CREBBP—salivary gland cancer	8.34e-05	0.000111	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CREBBP—salivary gland cancer	8.32e-05	0.000111	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—CREBBP—salivary gland cancer	8.31e-05	0.000111	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CCND1—salivary gland cancer	8.31e-05	0.000111	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PTEN—salivary gland cancer	8.21e-05	0.00011	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CCND1—salivary gland cancer	8.19e-05	0.000109	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—EP300—salivary gland cancer	8.11e-05	0.000108	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	8.03e-05	0.000107	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—PTEN—salivary gland cancer	8.02e-05	0.000107	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—PIK3CA—salivary gland cancer	7.96e-05	0.000106	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—PTEN—salivary gland cancer	7.91e-05	0.000106	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—CREBBP—salivary gland cancer	7.86e-05	0.000105	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—EP300—salivary gland cancer	7.83e-05	0.000105	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—PIK3CA—salivary gland cancer	7.83e-05	0.000104	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—PIK3CA—salivary gland cancer	7.81e-05	0.000104	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	7.66e-05	0.000102	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—EP300—salivary gland cancer	7.65e-05	0.000102	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—EP300—salivary gland cancer	7.54e-05	0.000101	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	7.27e-05	9.7e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—PIK3CA—salivary gland cancer	7.23e-05	9.64e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—PIK3CA—salivary gland cancer	7.11e-05	9.49e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—PIK3CA—salivary gland cancer	7.1e-05	9.47e-05	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PIK3CA—salivary gland cancer	6.89e-05	9.19e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—HRAS—salivary gland cancer	6.69e-05	8.92e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	6.63e-05	8.85e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—HRAS—salivary gland cancer	6.58e-05	8.78e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—HRAS—salivary gland cancer	6.57e-05	8.76e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—PIK3CA—salivary gland cancer	6.52e-05	8.7e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CREBBP—salivary gland cancer	6.43e-05	8.58e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—PIK3CA—salivary gland cancer	6.38e-05	8.52e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TP53—salivary gland cancer	6.31e-05	8.42e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—PIK3CA—salivary gland cancer	6.28e-05	8.38e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CREBBP—salivary gland cancer	6.27e-05	8.37e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CCND1—salivary gland cancer	6.27e-05	8.37e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TP53—salivary gland cancer	6.18e-05	8.24e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CCND1—salivary gland cancer	6.17e-05	8.23e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CCND1—salivary gland cancer	6.16e-05	8.21e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TP53—salivary gland cancer	6.08e-05	8.11e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PTEN—salivary gland cancer	6.05e-05	8.08e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—HRAS—salivary gland cancer	6.03e-05	8.05e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—PIK3CA—salivary gland cancer	6e-05	8e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PTEN—salivary gland cancer	5.96e-05	7.95e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PTEN—salivary gland cancer	5.94e-05	7.93e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PTEN—salivary gland cancer	5.94e-05	7.92e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CREBBP—salivary gland cancer	5.91e-05	7.89e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—HRAS—salivary gland cancer	5.91e-05	7.88e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CREBBP—salivary gland cancer	5.86e-05	7.82e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—HRAS—salivary gland cancer	5.81e-05	7.75e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TP53—salivary gland cancer	5.8e-05	7.74e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PIK3CA—salivary gland cancer	5.8e-05	7.73e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—EP300—salivary gland cancer	5.77e-05	7.7e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—EP300—salivary gland cancer	5.68e-05	7.58e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—EP300—salivary gland cancer	5.67e-05	7.56e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	5.67e-05	7.56e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—EP300—salivary gland cancer	5.66e-05	7.56e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—PIK3CA—salivary gland cancer	5.66e-05	7.55e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PTEN—salivary gland cancer	5.61e-05	7.48e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—PIK3CA—salivary gland cancer	5.58e-05	7.44e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—HRAS—salivary gland cancer	5.55e-05	7.4e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TP53—salivary gland cancer	5.47e-05	7.3e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TP53—salivary gland cancer	5.4e-05	7.2e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—EP300—salivary gland cancer	5.35e-05	7.14e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—HRAS—salivary gland cancer	5.23e-05	6.98e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—HRAS—salivary gland cancer	5.16e-05	6.89e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CREBBP—salivary gland cancer	5.01e-05	6.68e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PTEN—salivary gland cancer	4.59e-05	6.12e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PTEN—salivary gland cancer	4.48e-05	5.98e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—EP300—salivary gland cancer	4.38e-05	5.84e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—EP300—salivary gland cancer	4.27e-05	5.7e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PIK3CA—salivary gland cancer	4.27e-05	5.7e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PTEN—salivary gland cancer	4.22e-05	5.63e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PIK3CA—salivary gland cancer	4.2e-05	5.61e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PIK3CA—salivary gland cancer	4.19e-05	5.59e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PIK3CA—salivary gland cancer	4.19e-05	5.59e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PTEN—salivary gland cancer	4.19e-05	5.58e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TP53—salivary gland cancer	4.13e-05	5.51e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TP53—salivary gland cancer	4.06e-05	5.42e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TP53—salivary gland cancer	4.06e-05	5.41e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—EP300—salivary gland cancer	4.03e-05	5.37e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—EP300—salivary gland cancer	3.99e-05	5.33e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PIK3CA—salivary gland cancer	3.96e-05	5.28e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—HRAS—salivary gland cancer	3.95e-05	5.27e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—HRAS—salivary gland cancer	3.89e-05	5.19e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—HRAS—salivary gland cancer	3.88e-05	5.17e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CREBBP—salivary gland cancer	3.87e-05	5.16e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PTEN—salivary gland cancer	3.58e-05	4.77e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—EP300—salivary gland cancer	3.41e-05	4.55e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PIK3CA—salivary gland cancer	3.24e-05	4.32e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PIK3CA—salivary gland cancer	3.16e-05	4.22e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PIK3CA—salivary gland cancer	2.98e-05	3.97e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PIK3CA—salivary gland cancer	2.95e-05	3.94e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PTEN—salivary gland cancer	2.76e-05	3.68e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—EP300—salivary gland cancer	2.63e-05	3.51e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PIK3CA—salivary gland cancer	2.52e-05	3.37e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	1.95e-05	2.6e-05	CbGpPWpGaD
